Exhibit 10.1 


 





SEPARATION
AND RELEASE AGREEMENT


 


This
Separation and Release Agreement (the “Agreement”) is by and between Philippe Goix (“Executive”)
and Avant Diagnostics, Inc., a Nevada corporation (the “Company”).


 


WHEREAS,
Executive’s status as an employee and director of the Company will end effective on December 4, 2017 (the “Termination
Date”); and


 


WHEREAS,
Executive and the Company desire to assure a smooth and effective transition of Executive’s duties and to wind-up their
employment relationship amicably; and


 


WHEREAS,
the payments and benefits being made available to Executive pursuant to this Agreement are intended to satisfy all outstanding
obligations under that certain Offer Letter dated June 19, 2017, between Executive and the Company (the “Employment Agreement”).


 


NOW,
THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, Executive and the Company, intending
to be legally bound, hereby agree as follows:


 


1. Termination
Date . Executive acknowledges that his status as an officer and director of the Company will end on the Termination Date.
Executive understands that this Agreement is only effective if it is executed on or before December 15, 2017. Executive has seven
(7) days after Executive signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after
Executive signed this Agreement, so long as it has not been revoked by Executive before that date (the “Effective Date”).


 


2. Separation
Payments and Benefits . Without admission of any liability, fact or claim, the Company hereby agrees, subject to Executive’s
timely execution and non-revocation hereof and Executive’s compliance with Executive’s obligations pursuant to this
Agreement and the Surviving Provisions, to provide Executive the severance payments and benefits set forth below:


 


(a)  Severance
Payment. Upon the Company receiving in excess of $1,500,000 in aggregate gross proceeds from the sale of its equity and/or
debt securities on or after the Termination Date (the “Triggering Event”), the Company shall pay Executive
a lump sum cash payment of $27,346.84 within three (3) business days of the date such Triggering Event occurs.


 


(b)  Benefits
Coverage. If Executive is enrolled in the Company’s group medical, vision and/or dental plans on the Termination Date,
Executive may elect to continue Executive’s participation and that of Executive’s eligible dependents in those plans
for a period of time under COBRA. Executive may make such an election whether or not Executive accepts this Agreement. If Executive
timely elects to continue Executive’s participation and/or that of Executive’s eligible dependents in such plans,
Executive shall pay the full premium cost himself.


 






    	 	-1-	 



     


    

 


(c)  Taxes.
Executive understands and agrees that all payments under this Agreement, except for any expense reimbursement, will be subject
to appropriate tax withholding and other deductions, as and to the extent required by law.


 


(d)  Sole
Separation Benefit. Executive agrees that the payments and benefits provided by this Agreement are not required under the
Company’s normal policies and procedures and are provided solely in connection with this Agreement. Executive further acknowledges
and agrees that the payments and benefits referenced in this Agreement constitute adequate and valuable consideration, in and
of themselves, for the promises contained in this Agreement.


 


(e)  Continued
Obligations. Executive acknowledges and agrees that Executive shall continue to be subject to, and abide by, Section 8 (Employee
Inventions Assignment and Confidentiality Agreement) of the Employment Agreement (collectively, the “Surviving Provisions”),
which shall continue to apply and remain in full force and effect. The Executive further acknowledges and agrees that in order
to comply with the Surviving Provisions, from and after the Termination Date, Executive may not at any time nor in any venue speak
about, present or author any materials with respect to the Company or its products without the Company’s advance written
consent, whether at medical, clinical, investor or analyst presentations or otherwise, except upon request and at the direction
of the Company, other than (i) to his legal counsel or tax or financial advisors, (ii) as required by law or legal process, (iii)
to the limited extent necessary to defend himself against any claims (x) brought by the Company or (y) in relation to his work
for the Company, (iv) statements made by Executive regarding the Company and/or its products that do not breach the Surviving
Provisions or Section 6(b) hereof, or (v) statements made by Executive regarding (a) Executive’s former position, titles, achievements,
duties or responsibilities with the Company or any of its subsidiaries, or (b) Executive’s role at the Company and/or role with
respect to any Company products on which Executive worked, provided that (x) in the case of clauses (a) and (b), such statements
do not breach any of the Surviving Provisions or Section 6(b) of this Agreement, and (y) in the case of clause (b), such statements
contain only information about the Company or any of its products that is in the public domain or generally known within the industry.
(the foregoing clauses (i) through and including (v), the “Exceptions”)). In addition, the Executive agrees
that, if asked about the Company or its products by a third party having no involvement in Executive’s performance of his
obligations under Section 6(c), Executive will state that he is not an employee of the Company and, unless permitted by one of
the Exceptions (i) – (iii) or (v), will defer the question to the Company for response. If the Company believes that Executive
has breached any provision of this Agreement or the Surviving Provisions, then it shall provide Executive with written notice
of such alleged breach within 30 days after it has knowledge of the occurrence thereof and shall provide Executive with 30 days
to cure such alleged breach (any breach so cured shall not be deemed a breach of this Agreement or any of the Surviving Provisions).
If the Executive breaches this Agreement or any of the Surviving Provisions, and fails to cure said breach, the Company shall
have no further obligation to provide any payments pursuant to this Agreement.


 






    	 	-2-	 



     


    




 


3.
Full Payment; Termination of Employment Agreement . Other than as set forth in Section 2 above, Executive shall not be
entitled to any other payments including but not limited to bonuses, reimbursements, commissions, or other cash or non-cash awards,
penalties, interest or attorneys’ fees, and Executive expressly represents that Executive has been compensated for all monies
owed to Executive from Executive’s employment with the Company. On the Termination Date, all provisions of the Employment
Agreement, other than the Surviving Provisions and Section 9 of the Employment Agreement, shall terminate and Executive shall
have no further rights thereunder.


 


4.
General Release . As a material inducement for the Company to enter into this Agreement, and in exchange for the performance
of the Company’s obligations under this Agreement provided for herein, Executive knowingly and voluntarily waives and releases
all rights and claims, known and unknown, which Executive may have against the Company or any of its respective subsidiaries,
affiliates or successors, or any of their current or former officers, directors, managers, employees, shareholders, agents, insurance
carriers, auditors, accountants, attorneys or representatives (collectively, the “Releasees”), including any and all
charges, complaints, claims, liabilities, obligations, promises, agreements, contracts, controversies, damages, actions, causes
of action, suits, rights, demands, costs, losses, debts and expenses of any kind. This includes, but is not limited to, any claim
to any equity-based or similar type of award or incentive with respect to the Releasees, including any claim for benefits under
any stock option or other equity-based incentive plan of the Releasees (or any related agreement, arrangement or understanding
with any Releasee); any claim to accelerated vesting or post-termination or severance benefits or payments that are or may become
payable under any plan, arrangement, policy and agreement between Executive and the Company, including, without limitation, the
Employment Agreement, each stock option agreement entered into between Executive and the Company and any agreement or policy with
the Company under which Executive benefits, and any claims for employment discrimination, harassment, wrongful termination, constructive
termination, violation of public policy, breach of any express or implied contract, breach of any implied covenant, fraud, intentional
or negligent misrepresentation, emotional distress, defamation, or any other claims, actual or potential, which in any way arise
from or are related to Executive’s relationship with the Company, including, without limitation, relating to Executive’s
compensation, the termination of the employment relationship, or any other conduct of the Company occurring prior to the execution
of this Agreement. This also includes a release of any claims under any federal, state or local laws or regulations, including,
but not limited to Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000, et seq.; Americans with
Disabilities Act, as amended, 42 U.S.C. § 12101 et seq.; the Rehabilitation Act of 1973, as amended, 29 U.S.C. § 701
et seq.; Age Discrimination in Employment Act, as amended, 29 U.S.C. § 621, et seq.; Civil Rights Act of 1866, and Civil
Rights Act of 1991; 42 U.S.C. § 1981, et seq.; Equal Pay Act, as amended, 29 U.S.C. § 206(d); regulations
of the Office of Federal Contract Compliance, 41 C.F.R. Section 60, et seq.; The Family and Medical Leave Act, as amended, 29
U.S.C. § 2601 et seq.; the Fair Labor Standards Act of 1938, as amended, 29 U.S.C. § 201 et seq.; the Executive
Retirement Income Security Act, as amended, 29 U.S.C. § 1001 et seq.; the Worker Adjustment and Retraining Notification
Act, as amended, 29 U.S.C. § 2101 et seq.; the Federal False Claims Act, as amended, 31 U.S.C. §§ 3729
et seq.; the Dodd-Frank Wall Street Reform and Consumer Protection Act; the California Fair Employment and Housing Act, the California
Labor Code, the Maryland Wage Payment and Collection Law, Maryland’s wage and hour statutes; and any other federal, state
or local laws of similar effect. Notwithstanding the generality of the foregoing, Executive does not release any claims which
Executive may have to the following (collectively, the “Unreleased Claims”): (i) claims for unemployment compensation
or any state disability insurance benefits pursuant to the terms of applicable state law, (ii) Executive’s right to continued
participation in certain of the Company’s group benefit plans pursuant to the terms and conditions of COBRA, (iii) Executive’s
right to any payments and benefits under this Agreement (including, without limitation, any of the payments and benefits set forth
in Section 2), (iv) Executive’s right to vested benefits under the benefit plans of any Releasee, (v) Executive’s
right to indemnification pursuant to Section 9 of the Employment Agreement and (vi) Executive’s right to bring to the attention
of the Equal Employment Opportunity Commission claims of discrimination; provided, however, that Executive does release Executive’s
right to secure any damages for alleged discriminatory treatment. The matters that are the subject of the releases referred to
in this Section 4 (and, for the avoidance of doubt, excluding any Unreleased Claims) shall be referred to collectively as the
“Released Matters.”


 






    	 	-3-	 



     


    




 


5.
Acknowledgements Related to ADEA . Executive understands and acknowledges that:


 


(a)  This
Agreement constitutes a voluntary waiver of any and all rights and claims Executive has against the Releases, or any of them,
as of the date Executive executes this Agreement, for claims arising under the Age Discrimination in Employment Act, 29 U.S.C.
621, et seq.


 


(b)  Executive
has waived rights or claims pursuant to this Agreement and in exchange for consideration, the value of which exceeds payment or
remuneration to which Executive was already entitled.


 


(c)  Executive
is hereby advised to consult with an attorney of Executive’s choosing concerning this Agreement prior to executing it.


 


(d)  Executive
has been afforded a period of twenty-one (21) days to consider the terms of this Agreement, as required by the Older Workers Benefits
Protection Act, and in the event Executive should decide to execute this Agreement in fewer than twenty-one (21) days, Executive
has done so with the express understanding that Executive has been given and declined the opportunity to consider this Agreement
for a full twenty-one (21) days, and waives the balance of the twenty-one (21) day period.


 


(e)  Executive
may revoke this Agreement at any time during the seven (7) days following the date of execution of this Agreement, and this Agreement
shall not become effective or enforceable until such revocation period has expired. Executive understands that if Executive does
not sign this Agreement or Executive signs and subsequently revokes this Agreement before it becomes effective, Executive shall
not be entitled to any of the payments or benefits provided in Section 2 of this Agreement.


 


6. Transition;
Non-Disparagement; Cooperation; Transfer of Company Property . Executive further agrees that:


 


(a)  Transition.
Both parties agree that it shall not make any internal or external communication addressing Executive’s separation without
the other parties consent and agrees that if Company determines to develop and issue any internal or external communication regarding
Executive’s separation, Executive may collaborate with Company regarding said communication.


 






    	 	-4-	 



     


    










 


(b)  Non-Disparagement.
Executive agrees that Executive shall not at any time disparage or encourage or induce others to disparage the Company, any of
its subsidiaries, or any of their respective past and present, officers, directors, employees, products or services (the “Company
Parties”). The Company agrees that it shall (i) instruct its present directors and officers not to disparage or encourage
or induce others to disparage the Executive or his reputation (together, the “Executive Parties”) at any time
during which they are employed by, or providing services to, the Company, and (ii) not cause or direct any of its past or present
employees or independent contractors to disparage or encourage or induce others to disparage any of the Executive Parties. For
purposes of this Section 6(b), the term “disparage” includes, without limitation, comments or statements to the press,
to the Company’s or any subsidiaries’ employees or to any individual or entity with whom the Executive, the Company
or any subsidiary thereof has a business relationship (including, without limitation, any vendor, supplier, customer or distributor),
or any public statement, that in each case is intended to, or can be reasonably expected to, damage any of the Company Parties
or the Executive Parties, as applicable. Notwithstanding the foregoing, nothing in this Section 6(b) shall prevent any person
from making any truthful statement to the extent, but only to the extent (A) necessary with respect to any litigation, arbitration
or mediation in the forum in which such litigation, arbitration or mediation properly takes place, or (B) required by law, legal
process or by any court, arbitrator, mediator or administrative or legislative body (including any committee thereof) with apparent
jurisdiction over such person.


 


(c)  Cooperation.
Commencing on the date hereof and continuing during the eighteen (18) month period after the Termination Date (the “Cooperation
Period”), Executive agrees to reasonably cooperate with the Company in its efforts (i) to prosecute or defend itself
against any claim, suit, demand or cause of action (not brought by the Company against Executive or by Executive against the Company)
about which Executive has knowledge and (ii) with dealing with outside vendors about which Executive has knowledge. Notwithstanding
the immediately preceding sentence, following the Termination Date, (a) the Company shall provide Executive with advance written
notice of such required cooperation within a reasonable period of time prior to the date on which such cooperation will be required,
(b) such cooperation shall not create a conflict with any of Executive’s obligations or duties to his then current employer,
(c) such cooperation shall be provided at times and locations, and in a manner, that are mutually agreed between the Company and
Executive, (d) Executive shall not be required to devote more than 10 hours per month in providing any such cooperation, (e) the
Executive shall report to, and take direction from, only the Company’s Chief Executive Officer in providing the cooperation
described above and (f) the Company shall reimburse Executive (in compliance with Code Section 409A) for all reasonable expenses
incurred by him in complying with the above sentence, subject to appropriate itemization and substantiation of such expenses.
You agree that, in the event you are subpoenaed by any person or entity (including, but not limited to, any government agency)
to give testimony (in a deposition, court proceeding or otherwise) which in any way relates to your employment by the Company,
you will give prompt notice of such request to the Company, and will make no disclosure until the Company has had a reasonable
opportunity to contest the right of the requesting person or entity to such disclosure as long as compliance herewith does not
require you to violate the law or the terms of the subpoena.


 






    	 	-5-	 



     


    




 


(d)  Return
of Company Property. Executive represents that on or before the Termination Date, Executive will return to the Company all
written Confidential Information (as defined in Section 9) in Executive’s possession (including, but not limited to, Company-provided
credit cards, building or office access cards, keys, computer or other business equipment, manuals, files, documents, records,
software, employee database and other data), and that Executive will not retain any copies, compilations, extracts, excerpts,
abstracts, summaries or other notes of any such manuals, files, documents, records, software, customer or employee database or
other data files, memoranda, records, and other documents, and any other physical or personal property which are the property
of the Company and which Executive had in Executive’s possession, custody or control, including any computers, cellular
phones, tablets, PDAs or similar business equipment; and provided, further, that if Executive has inadvertently retained non-material
Confidential Information or property of the Company (“Covered Information”), it shall not be a breach of this
Agreement or any of the Surviving Provisions if (i) promptly after becoming aware of his possession of such Covered Information
Executive returns it to the Company, (ii) Executive has not disclosed such Covered Information in violation of the Surviving Provisions,
and (iii) no loss or damage that is more than de minimis has been caused to the Company as a result of Executive’s retention
of such Covered Information. Notwithstanding this Section 6(d), the Company may provide Executive with Confidential Information
and Company property in connection with his obligations under Section 6(c) hereof and Executive acknowledges and agrees that he
shall return all such Confidential Information and Company property within ten (10) days after the end of Executive’s obligations
under Section 6(c) hereof or such earlier date as is requested reasonably in advance in writing by the Company (with the same
procedures to apply regarding the inadvertent retention of Covered Information as set forth in the immediately preceding sentence).


 


7. Executive
Representations . Executive warrants and represents that (a) Executive has not filed or authorized the filing of any complaints,
charges or lawsuits against the Company with any governmental agency or court regarding any claims released in this Agreement,
and that if, unbeknownst to Executive, such a complaint, charge or lawsuit has been filed on Executive’s behalf, Executive
will immediately cause it to be withdrawn and dismissed, (b) Executive has reported all hours worked as of the date of this Agreement
and has been paid all compensation, wages, bonuses, commissions, and/or benefits to which Executive may be entitled and no other
compensation, wages, bonuses, commissions and/or benefits are due to Executive, except as provided in this Agreement, (c) Executive
has no known workplace injuries or occupational diseases and has been provided and/or has not been denied any leave requested
under the Family and Medical Leave Act or any state law counterpart, (d) the execution, delivery and performance of this Agreement
by Executive does not and will not conflict with, breach, violate or cause a default under any agreement, contract or instrument
to which Executive is a party or any judgment, order or decree to which Executive is subject, (e) Executive is executing this
Agreement voluntarily and without any duress or undue influence on the part or behalf of the Company, with full understanding
of the terms and consequences, (f) upon the execution and delivery of this Agreement by the Company and Executive, this Agreement
will be a valid and binding obligation of Executive, enforceable in accordance with its terms and (g) the Executive agrees and
acknowledges that in executing this Agreement he does not rely and has not relied on any representation or statement by any of
the Company Parties with regard to the subject matter, basis or effect of this Agreement..


 






    	 	-6-	 



     


    




 


8.  The
Company’s Release of Executive. In consideration for mutual covenants and agreements of the Parties set forth in this
Agreement and for other good and valuable consideration, the receipt and sufficiency of which the Parties acknowledge, the Company,
for itself and for and on behalf of its affiliates, shareholders, directors, officers and agents, hereby releases and forever
discharges Executive, and each of Employee’s heirs, beneficiaries, assigns, executors, administrators and representatives
(the “Executive Released Parties”), of and from any and all manner of actions and causes of action, suits,
debts, claims, and demands whatsoever, in law or equity, known or unknown, asserted or unasserted, which it ever had, now has,
or hereafter may have arising out of or relating to Executive’s employment with the Company or service on the Company’s
Board of Directors (the “Board”) or as its Chief Executive Officer, the termination of his employment or Board
service with the Company, and/or any other fact, matter, incident, claim, injury, event, circumstance, happening, occurrence,
and/or thing of any kind or nature which arose or occurred, in whole or in part, prior to the date when the Company executes this
Agreement. Notwithstanding the foregoing, in the event that Executive is named as a defendant in any shareholder derivative action
or is threatened to be made a party to any such action, Executive shall be entitled to be indemnified by the Company to the full
extent permitted by law and Section 8 of the Employment Agreement. Nothing contained herein shall release Executive from his obligations
set forth in this Agreement.


 


9.  Confidential
Information. You agree that you will not, directly or indirectly, use, disclose, furnish or make accessible to any third party
any confidential, sensitive and/or proprietary information learned, discovered, developed, conceived or prepared by you during
or as a result of your employment by the Company. For purposes of this Paragraph, confidential, sensitive and/or proprietary information
shall include but not be limited to: customer information, financial information, business plans and policies, methods of operation,
strategic initiatives, and business development plans; it shall not include any information which (i) was rightfully known
by you prior to your employment by the Company; (ii) becomes publicly available without any fault or involvement by you;
or (iii) is generally known prior to the date upon which you propose to use, disclose, furnish or make assessable to any
third party such information. Nothing herein precludes you from responding to an order of a court or governmental agency or subpoena,
provided you comply with Section 6(c).


 


10. Governing
Law. This Agreement shall be construed and enforced in accordance with, and the rights of the parties hereunder shall be governed
by, the laws of New York, without regard to any principles of conflicts of laws.


 


11.
Section 409A. It is intended that each installment of the payments provided hereunder constitute separate “payments”
for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). It is further intended that payments hereunder satisfy, to the
greatest extent possible, the exemption from the application of Code Section 409A provided under Treasury Regulation Section 1.409A-1(b)(4)
(as a “short-term deferral”). To the extent that any provision of this Agreement is ambiguous as to its compliance
with Code Section 409A, the provision will be read in such a manner so that all payments hereunder comply with Code Section 409A.
To the extent any expense reimbursement or the provision of any in-kind benefit under this Agreement is determined to be subject
to Code Section 409A, the amount of any such expenses eligible for reimbursement, or the provision of any in-kind benefit, in
one calendar year shall not affect the expenses eligible for reimbursement, or the amount of in-kind benefits to be provided,
in any other calendar year (except for any lifetime or other aggregate limitation applicable to medical expenses), in no event
shall any expenses be reimbursed after the last day of the calendar year immediately following the calendar year in which Executive
incurred such expenses, and in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to
liquidation or exchange for another benefit.


 






    	 	-7-	 



     


    




 


12.  Non-Admission
of Liability. This Agreement and the fact that it was offered are not and shall not in any way be construed as admissions
by the Company that it violated any federal, state or local law, statute or regulation, or that it acted wrongfully with respect
to the Executive or to any other person or entity in any manner. The Company specifically disclaims any liability to or wrongful
acts against the Executive or any other person or entity.


 


13.  Civil
Code Section 1542. Executive understands and agrees that this Agreement is intended to include all claims, if any, which he
may have against the Company, including those which he does not now know or suspect to exist in his favor against the Company,
and that this Agreement extinguishes those claims as well. Accordingly, Executive specifically waives any rights which may accrue
or arise under the provisions of California Civil Code section 1542 which provides as follows:


 


“A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME
OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.”


 


Executive,
being aware of said code section, agrees to expressly waive any rights he may have thereunder, as well as under any other similar
statute of the State of Maryland or other law or common law principles of similar effect.


 


14.  Non-Admissibility.
Neither this Agreement nor anything in this Agreement shall be construed to be or shall be admissible in any proceeding as evidence
of or an admission by the Company or the Executive of any violation of any state, federal or local laws or regulations or any
rules, regulations, criteria or standards of any regulatory body. This Agreement may be introduced, however, in any proceeding
to enforce the Agreement.


 






    	 	-8-	 



     


    




 


15. Miscellaneous.
This Agreement, together with the Surviving Provisions and Section 9 of the Employment Agreement, is the entire agreement between
the parties with regard to the subject matter hereof. Executive and the Company acknowledge that there are no other agreements,
written, oral or implied regarding such subject matter, and that neither the Company nor Executive may rely on any prior negotiations,
discussions, representations or agreements regarding the subject matter hereof. Whenever possible, each provision of this Agreement
shall be interpreted in a manner as to be effective and valid under applicable law, but if any provision shall be held to be prohibited
or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without
invalidating or affecting the remainder of such provision or any of the remaining provisions of this Agreement. The Company represents
that the Board of Directors of the Company has duly and validly authorized this Agreement. This Agreement may be modified only
in writing, and such writing must be signed by both Executive and the Company and recited that it is intended to modify this Agreement.





 


16.  Notice:
All notices, requests, demands and other communications hereunder to either party shall be in writing and shall be delivered,
either by hand, by facsimile, by overnight courier or by certified mail, return receipt requested, duly addressed as indicated
below or to such changed address as the party may subsequently designate:


 


To
the Company:


 


Avant
Diagnostics, Inc.


217
Perry Parkway, Suite 8





Gaithersburg,
MD 20877





Attention:
Chief Executive Officer


 


with
a copy to (which shall not constitute notice):





 


Sheppard,
Mullin, Richter & Hampton LLP





30
Rockefeller Plaza





New
York, New York 10112





Attn:
Stephen A. Cohen, Esq.





Email:
scohen@sheppardmullin.com


 


To
the Executive:





Philippe
Goix





[ADDRESS]





Email:


 


17.  Binding
Effect: This Agreement shall be binding upon the Parties and upon their dependents, heirs, representatives, executors, administrators,
successors and assigns, and shall inure to the benefit of the Parties and their respective dependents, heirs, representatives,
executors, administrators, successors and assigns.


 


18.  No
Presumption. This Agreement shall be construed and interpreted as if all of its language were prepared jointly by the Executive
and the Company. No language in this Agreement shall be construed against a party on the ground that such party drafted or proposed
that language.


 


19.  Execution
of Counterparts. This Agreement may be executed in counterparts, but shall be construed as if signed in one document. Facsimile
or electronically transmitted signatures shall be given the same force and effect as original signatures with the Parties to provide
original signatures as soon as practicable.


 


20.  Further
Actions. The Company and Executive agree that in case at any time after the Termination Date any further action is
necessary or desirable to carry out the purposes of this Agreement, including any documents requested by any underwriter or
placement agent in connection with any offering of the Company’s equity and/or debt securities, each of the parties
hereto will take such further action (including without limitation, the execution and delivery of such further instruments
and documents) as any other party hereto may reasonably request in order to carry out the intent and accomplish the purposes
of this Agreement and the consummation of the transactions contemplated hereby.


 


(signature
page follows)


 






    	 	-9-	 



     


    

 


IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered as of the dates indicated below.


 





	 	EXECUTIVE
	 	 
	 	/s/ Philppe Goix
	 	Philippe Goix
	 	Date: December 15, 2017
	 	 
	 	COMPANY
	 	 
	 	/s/ Scott VanderMeer
	 	Name: Scott VanderMeer
	 	Title: Interim CFO
	 	Date: December 15, 2017







 


 






    	 	-10-